19 May 2023
33rd Fine Chemicals Group Postgraduate Symposium
Organised by:
SCI’s Fine Chemicals Group and SCI's Young Chemists' Panel
University of Newcastle, UK / Online Webinar (Hybrid)
Registration Closed
This event is no longer available for registration.
Share this event
Synopsis
This conference will showcase exceptional research from final year PhD students and provides the opportunity to network and share ideas. The subjects covered will be wide ranging within organic chemistry such as synthesis, mechanistic studies, methodology, medicinal chemistry or analysis and computational.
Attendees
The majority of attendees are expected to be academic and industrial researchers including postgraduate students who will be presenting their work, but this event is open to all and free to attend.
The event will be run as a hybrid event which allows remote attendance in addition to in person attendance. Please select only one option when registering (in-person OR online attendance).
Sponsorship
For further information and prices, please email conferences@soci.org. Spaces are limited and will be allocated on a first come, first served basis.
Programme
Friday 19 May 2023
- 10:30
- Registration and refreshments
- 11:30
- Welcome and introduction
Session 1
- 11:35
- Towards the Total Synthesis of the Nonribosomal Pentapeptide Siderophore Madurastatin C1
Damon Wen, Newcastle University - 12:00
- Stereoselective Two-Carbon Ring Expansion of Allylic Amines via Electronic Control of Palladium-Promoted Equilibria
Charles Mikan, Northumbria University - 12:25
- Light-Mediated Multi-Target Protein Degradation using Arylazopyrazole Photoswitchable PROTACs (AP-PROTACs)
Qisi Zhang, Imperial College London - 12:50
- Lunch
Session 2
- 13:50
- A New Synthesis of Azetidines
Hannah Askey, University of Bath - 14:15
- Chemoenzymatic Total Synthesis of the Antibiotic (-)-13-Deoxytetrodecamycin
Joe Russell, University of Bristol - 14:40
- Harnessing triaryloxonium ions for aryne generation
Madeleine Hindson, University of Oxford - 15:05
- A ‘direct-to-biology’ platform for the rapid identification and optimisation of novel, irreversible antivirals
Harry Wilders, GlaxoSmithKline/Strathclyde University - 15:30
- Refreshment break
Session 3
- 15:50
- Investigation into the mechanism of a photoredox catalysed C(sp3)–H functionalisation reaction using kinetic analysis in flow: radical insights for selectivity
Hannah Broderick, Imperial College London - 16:15
- A reaction with potential: an electrosynthesis of 1,3,4-Oxadiazoles from N-Acyl Hydrazones
Luke Chen, GlaxoSmithKline/Strathclyde University - 16:40
- Iron-Catalysed Regioselective C–H Thiocyanation of Arenes
Lachlan Waddell, University of Glasgow - 17:05
- Judging and discussions
- 17:15
- Prize giving and closing remarks
SCI’s Young Chemists’ Panel are committed to promoting diversity and equality in the chemical sciences. We aim to identify high quality speakers for all our conferences with inclusivity of gender and ethnicity. Attendees from all backgrounds and ages are welcome.
Venue and Contact
University of Newcastle
Newcastle upon Tyne
NE1 7RU
Conference Team
Tel: +44 (0)20 7598 1561
Email: conferences@soci.org
Fees
This event is free to attend.
To enable us to control the number of visitors into the building, we are asking all delegates to pre-register in advance.
For this reason, registration will close 24 hours prior to the event and only registered guests will be admitted.
All registrations will automatically receive a confirmation within 24 hours of registering for the event. Should you not receive written confirmation of your booking, please email conferences@soci.org.
Become an SCI Member and save on this and future events
See Membership OptionsSign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Booking Process/Deadlines
CPD Info
All delegates attending this meeting are able to claim CPD points.
Sponsors
Organising committee
Charlotte Dalton, CatSci
David Fengas, Concept Life Sciences
Chris Jones, QMUL
Daniel Jones, Sosei Heptares
Helen Jones, AstraZeneca
Tom Sturgeon, SCI
